The authors concluded that antidepressants seem effective for late-life depression but effects are modest and variable; adverse effects are significantly more likely with antidepressants than with placebo. The review was well-conducted and these conclusions appear reliable, with the proviso that the number of trials was small and that the results may not be generalisable to the frail elderly.
Data extraction
For binary outcomes, odds ratios (ORs) and absolute risk differences (RDs) with 95% confidence intervals (CIs) were calculated from the number of events occurring in the two groups. For continuous outcomes mean differences between the change score in the two groups were calculated, with 95% CIs. If the standard deviation (SD) of change scores was not reported or not calculable, it was imputed using the largest SD reported in other studies. Where studies reported two different formulations of antidepressant they were combined; where two different doses were utilised they were not combined. An intention to treat approach was used, using the last observation carried forward in participants with one or more outcome measure. Where studies did not report complete information, it was obtained through other data presentations or by contact with trial personnel.
Data were extracted by one reviewer and checked by a second, with discrepancies resolved by consensus.
Methods of synthesis
Data were combined using a Peto fixed-effect model to calculate pooled ORs, RDs, and 95% CIs for each outcome, weighted for study sample size and event rate. In addition, pooled event rates for each group were expressed as a percentage, and numbers needed to treat (NNT) were reported for the primary outcomes. For continuous data, mean differences were combined to obtain weighted mean differences (WMDs), 95% CIs and p values, using an inverse variance fixed effect model weighted for sample size. Heterogeneity was assessed using the χ2 test and I 2 statistic, with p<0.20 and 50% (respectively) taken to indicate heterogeneity. Where heterogeneity was detected, the effect on the I 2 statistic of excluding individual studies was investigated. The effect of a random-effects model was also tested. Publication bias was assessed using a funnel plot.
Subgroup analyses were conducted to assess whether effects differed between selective serotonin reuptake inhibitors (SSRIs) and other drugs and whether study duration affected outcomes. Differences between subgroups were investigated with the χ2 test.
Results of the review
Ten randomised controlled trials (RCTs) with 13 comparisons were included (n=4237, sample size ranged from 174 to 747). The Jadad score of the included studies was 4 or 5 (out of 5), denoting good to excellent quality. Drop-out rates across study groups ranged from 11 to 36%.
Response and remission (10 RCTs, 13 comparisons)Response and remission rates were significantly higher in the intervention group; response rates OR 1.40 (95% CI: Heterogeneity There was significant heterogeneity in rates of response (p=0.003, I 2 =64.6%) and remission (p=0.001, I 2 =67.5%), depression scores (p=0.02, I 2 = 53.3%) and discontinuations due to adverse effects (p=0.002, I 2 =61.1%). A single RCT was responsible for about half the variability due to heterogeneity. This RCT had the highest placebo response rate and involved many centres. The funnel plot showed no evidence of publication bias.
Subgroup analysesThe effects of SSRIs appeared similar to those of other antidepressants (8 RCTs, 10 comparisons). Response rates were significantly higher in the 10 to 12 week studies than the 6 to 8 week studies (p<0.01).
Authors' conclusions
Antidepressants seem effective for late-life depression but effects are modest and variable. Adverse effects are significantly more likely with antidepressants than with placebo.
CRD commentary
The objectives and inclusion criteria of the review were clear, relevant sources were searched for published and unpublished studies and suitable criteria were used to assess validity. Steps were taken to minimise the risk of bias and error, by having more than one reviewer independently involved in study selection and data extraction, though it is unclear whether this also applied to validity assessment. Appropriate statistical methods were used to combine studies and to check for heterogeneity and publication bias. Potential sources of heterogeneity were appropriately investigated by subgroup analyses and by discussion in the text, which highlighted the marked clinical and methodological differences between the studies. However, it should be noted that there were discrepancies between the numbers cited
